Department of Medicine, Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School
Boston, Massachusetts, United States
Matthew Frigault, MD (MGH) is a bone marrow transplant and cellular therapy physician with extensive preclinical, clinical and translational research experience involving the use of immune effector cell therapy for hematologic and solid tumor malignancies. His work has focused on high risk patient populations, rare tumor subtypes and immunomodulatory approaches for toxicity mitigation and augmentation of T cell function. Matthew is an Assistant Professor at Harvard Medical School and the Clinical Director of the Cellular Immunotherapy Program at Massachusetts General Hospital.
